Have your own idea? Try our Stock Screener
Over the last 7 days, the Life Sciences industry has dropped 3.2%, driven by a pullback from Thermo Fisher Scientific of 2.9%. In contrast, Illumina has gained 8.3%. This takes the industry's 12 month performance to a gain of 14%. Earnings are forecast to grow by 18% annually.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 09 Oct 2024 | US$728.8b | US$141.8b | US$8.5b | 36.9x | 85.8x | 5.1x |
Fri, 06 Sep 2024 | US$734.8b | US$141.8b | US$8.5b | 37.3x | 86.5x | 5.2x |
Sun, 04 Aug 2024 | US$742.2b | US$140.9b | US$11.3b | 37.3x | 65.9x | 5.3x |
Tue, 02 Jul 2024 | US$680.5b | US$141.3b | US$12.2b | 38.3x | 55.9x | 4.8x |
Thu, 30 May 2024 | US$716.0b | US$141.5b | US$12.4b | 37.5x | 57.6x | 5.1x |
Sat, 27 Apr 2024 | US$709.7b | US$141.6b | US$12.7b | 39.2x | 55.8x | 5x |
Mon, 25 Mar 2024 | US$749.2b | US$142.1b | US$12.8b | 44.7x | 58.4x | 5.3x |
Wed, 21 Feb 2024 | US$714.0b | US$142.2b | US$12.5b | 42.7x | 56.9x | 5x |
Fri, 19 Jan 2024 | US$681.8b | US$153.8b | US$14.2b | 35.4x | 48.1x | 4.4x |
Sun, 17 Dec 2023 | US$684.6b | US$153.7b | US$14.2b | 37.1x | 48.1x | 4.5x |
Tue, 14 Nov 2023 | US$581.9b | US$153.8b | US$14.0b | 31x | 41.7x | 3.8x |
Thu, 12 Oct 2023 | US$646.8b | US$154.6b | US$11.2b | 33.6x | 57.7x | 4.2x |
Sat, 09 Sep 2023 | US$705.6b | US$154.6b | US$11.2b | 31.6x | 63x | 4.6x |
Mon, 07 Aug 2023 | US$725.8b | US$154.7b | US$11.3b | 30.2x | 64.5x | 4.7x |
Wed, 05 Jul 2023 | US$691.6b | US$152.4b | US$12.5b | 29.6x | 55.3x | 4.5x |
Fri, 02 Jun 2023 | US$675.5b | US$152.2b | US$12.5b | 27.2x | 54x | 4.4x |
Sun, 30 Apr 2023 | US$699.4b | US$152.9b | US$9.4b | 29.2x | 74.1x | 4.6x |
Tue, 28 Mar 2023 | US$708.5b | US$154.5b | US$10.8b | 26.2x | 65.5x | 4.6x |
Thu, 23 Feb 2023 | US$721.8b | US$154.3b | US$10.9b | 31.1x | 66x | 4.7x |
Sat, 21 Jan 2023 | US$769.6b | US$155.3b | US$8.5b | 30.9x | 90.3x | 5x |
Mon, 19 Dec 2022 | US$742.7b | US$155.2b | US$8.8b | 28.5x | 84.6x | 4.8x |
Wed, 16 Nov 2022 | US$777.2b | US$154.9b | US$8.8b | 29.1x | 87.8x | 5x |
Fri, 14 Oct 2022 | US$705.7b | US$152.5b | US$17.0b | 23.8x | 41.5x | 4.6x |
Sun, 11 Sep 2022 | US$800.8b | US$152.3b | US$17.3b | 30.6x | 46.3x | 5.3x |
Tue, 09 Aug 2022 | US$824.5b | US$151.9b | US$18.2b | 33.4x | 45.3x | 5.4x |
Thu, 07 Jul 2022 | US$731.3b | US$148.1b | US$20.1b | 30.7x | 36.4x | 4.9x |
Sat, 04 Jun 2022 | US$756.2b | US$148.1b | US$20.1b | 31.2x | 37.6x | 5.1x |
Mon, 02 May 2022 | US$777.1b | US$150.9b | US$21.1b | 31.2x | 36.8x | 5.1x |
Wed, 30 Mar 2022 | US$871.0b | US$146.0b | US$25.4b | 37.3x | 34.3x | 6x |
Fri, 25 Feb 2022 | US$833.4b | US$146.2b | US$25.3b | 37x | 32.9x | 5.7x |
Sun, 23 Jan 2022 | US$836.8b | US$138.0b | US$27.3b | 39.3x | 30.6x | 6.1x |
Tue, 21 Dec 2021 | US$958.1b | US$138.0b | US$27.3b | 43.5x | 35.1x | 6.9x |
Thu, 18 Nov 2021 | US$971.5b | US$137.8b | US$27.1b | 47.9x | 35.8x | 7.1x |
Sat, 16 Oct 2021 | US$714.0b | US$106.0b | US$18.5b | 46.4x | 38.5x | 6.7x |
38.5x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.57% | |
Healthcare | -0.80% | |
Life Sciences | -2.17% | |
Clinical Research and Equipment | -2.17% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ILMN Illumina | US$139.66 | 8.3% +US$1.7b | 0.6% | PS5x | |
ICLR ICON | US$287.56 | 1.1% +US$252.6m | 18.4% | PE33.3x | |
MEDP Medpace Holdings | US$338.16 | 1.4% +US$145.7m | 37.2% | PE30.8x | |
BIO Bio-Rad Laboratories | US$339.22 | 0.5% +US$42.6m | -7.1% | PS3.7x | |
WAT Waters | US$358.91 | 0.2% +US$34.4m | 33.5% | PE35.8x |